<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on November 19, 2021</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT02179385</url>
  </required_header>
  <id_info>
    <org_study_id>0130-13-COM</org_study_id>
    <nct_id>NCT02179385</nct_id>
  </id_info>
  <brief_title>Empowerment and Support for the Diabetic Patient</brief_title>
  <acronym>CHANGE-D</acronym>
  <official_title>Coaching for Health to Achieve New Goals in Empowerment for Diabetes</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Clalit Health Services</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
    <collaborator>
      <agency>Merck Sharp &amp; Dohme Corp.</agency>
      <agency_class>Industry</agency_class>
    </collaborator>
  </sponsors>
  <source>Clalit Health Services</source>
  <brief_summary>
    <textblock>
      CHANGE-D objectives are to evaluate to what extent personal coaching for healthy lifestyle&#xD;
      and treatment adherence improves clinical outcomes among uncontrolled diabetic patients.&#xD;
&#xD;
      Evaluate to what extent personal coaching for healthy lifestyle and treatment adherence&#xD;
      improves self treatment among uncontrolled diabetic patients.&#xD;
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      Research Group 300 type 2 diabetics: 150 from Jewish sector and 150 from Arab sector will be&#xD;
      recruited from 7-10 clinics in each district: North District and Haifa District A personal&#xD;
      coaching intervention will be tailored from the offered tools: Face to face, group, telephone&#xD;
      Participants will be monitored for clinical and self treatments outcomes Comparison Group 300&#xD;
      patients with similar characteristics to the research group will receive Clalit's standard of&#xD;
      care Participants will be monitored for clinical and self treatments outcomes like the&#xD;
      research group&#xD;
    </textblock>
  </detailed_description>
  <overall_status>Unknown status</overall_status>
  <last_known_status>Active, not recruiting</last_known_status>
  <start_date>June 2014</start_date>
  <primary_completion_date type="Anticipated">June 2016</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <primary_purpose>Supportive Care</primary_purpose>
    <masking>None (Open Label)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Clinical composite</measure>
    <time_frame>0, 6, 12, 18 months from randomization</time_frame>
    <description>Change from baseline in a composite endpoint of HbA1c, BMI, Blood Pressure, Lipids at 6, 12 and 18 months from randomization</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>Change in Self Treatment Score</measure>
    <time_frame>0, 6, 12, 18 months from randomization</time_frame>
    <description>Change from baseline in Self treatment diabetes questionnaire score at 6, 12 and 18 months from randomization</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Change in Self Efficacy Score</measure>
    <time_frame>0, 6, 12, 18 months from randomization</time_frame>
    <description>Change from baseline in Self Efficacy questionnaire score at 6, 12 and 18 months from randomization</description>
  </secondary_outcome>
  <other_outcome>
    <measure>Change in Quality of life score</measure>
    <time_frame>0, 12 months from randomization</time_frame>
    <description>Change from baseline in Diabetes Quality of Life questionnaire score at 12 months from randomization</description>
  </other_outcome>
  <number_of_arms>2</number_of_arms>
  <enrollment type="Anticipated">300</enrollment>
  <condition>Type 2 Diabetes</condition>
  <arm_group>
    <arm_group_label>Health coaching</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>Patients receive health coaching via the phone, face to face or group support, according to patients' choice</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Standard of Care</arm_group_label>
    <arm_group_type>Placebo Comparator</arm_group_type>
  </arm_group>
  <intervention>
    <intervention_type>Behavioral</intervention_type>
    <intervention_name>Health Coaching</intervention_name>
    <arm_group_label>Health coaching</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:&#xD;
&#xD;
          -  Type 2 diabetes&#xD;
&#xD;
          -  At least one oral anti diabetic drug&#xD;
&#xD;
          -  HbA1c above 7.5% ot above 0.5% of personal target&#xD;
&#xD;
          -  Preparedness for change&#xD;
&#xD;
          -  Fluent Hebrew or Arabic&#xD;
&#xD;
        Exclusion Criteria:&#xD;
&#xD;
          -  Type 1 diabetes&#xD;
&#xD;
          -  Pregnancy or lactation&#xD;
&#xD;
          -  Incompetency to sign consent&#xD;
&#xD;
          -  Participation in another clinical trial&#xD;
&#xD;
          -  Unstable psychotic disease&#xD;
&#xD;
          -  Complex health condition&#xD;
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>21 Years</minimum_age>
    <maximum_age>75 Years</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <verification_date>August 2015</verification_date>
  <study_first_submitted>June 25, 2014</study_first_submitted>
  <study_first_submitted_qc>June 30, 2014</study_first_submitted_qc>
  <study_first_posted type="Estimate">July 1, 2014</study_first_posted>
  <last_update_submitted>August 4, 2015</last_update_submitted>
  <last_update_submitted_qc>August 4, 2015</last_update_submitted_qc>
  <last_update_posted type="Estimate">August 6, 2015</last_update_posted>
  <responsible_party>
    <responsible_party_type>Principal Investigator</responsible_party_type>
    <investigator_affiliation>Clalit Health Services</investigator_affiliation>
    <investigator_full_name>Margalit (Margita) Goldfracht</investigator_full_name>
    <investigator_title>Department Manager of Quality Promotion, Community Medical Division</investigator_title>
  </responsible_party>
  <keyword>Type 2 diabetes</keyword>
  <keyword>Type II diabetes</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Diabetes Mellitus</mesh_term>
    <mesh_term>Diabetes Mellitus, Type 2</mesh_term>
  </condition_browse>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

